Brenda M Gannon

5PUBLICATIONS
11CO-AUTHORS
Toxicology (incl. clinical toxicology)Biomolecular modelling and designBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 04, 2025
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.

Jack E Henningfield, Sandra D Comer, Matthew L Banks

|Sep 18, 2024
A "Furious" Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics.

William E Fantegrossi, Brenda M Gannon

|Jun 07, 2024
The Development of Cannabinoids as Therapeutic Agents in the United States.

Conor H Murray, Brenda M Gannon, Peter J Winsauer

|Jan 25, 2024
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.

Hannah E Shaw, Dylan R Patel, Brenda M Gannon

|Feb 10, 2022
Application of dose-addition analyses to characterize the abuse-related effects of drug mixtures.

Michelle R Doyle, Brenda M Gannon, Melson P Mesmin

Pageof 1

Frequent Collaborators

3 joint publications

William E Fantegrossi

2 joint publications

Ziva D Cooper

1 joint publications

Michelle R Doyle

1 joint publications

Gregory T Collins